Drugs / DWPUR001
last change Feb 2019 re-read 3 minutes ago

DWPUR001

Developed for
chronic hepatitis B virus infection
Investigated by
Daewoong Pharmaceutical Co. LTD. · Uijeongbu St. Mary Hospital

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02966964 Apr 2015 → Nov 2018 chronic hepatitis B virus infection Uijeongbu St. Mary Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DWPUR001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02966964 ↗
Route Oral “all randomized subjects take two pills of DWPUR001 or Placebo” NCT02966964 ↗